Back    Zoom +    Zoom -
<Research> JPM Raises WUXI APPTEC (02359.HK) TP to HKD172, Maintains Overweight
Recommend
3
Positive
4
Negative
2
JPM released a research report stating that WUXI APPTEC (02359.HK) (603259.SH) delivered 1Q results that significantly exceeded expectations across multiple fronts, with the share price surging 14% in a single day following the results announcement. The earnings conference call further confirmed that performance was far above expectations, and margins for fiscal year 2026 are expected to surpass those of 2025. Demand growth appears broad-based, with strong small molecule research and development and manufacturing (D&M) driven not only by oral GLP-1. Management also hinted at a possible update to full-year guidance when releasing 2Q results. JPM believes the strong 1Q margins reflect improvements in business mix and execution capability rather than short-term one-off factors.

JPM maintained its Overweight rating on WUXI APPTEC, reiterating it as one of its top picks in the China CXO sector. The H-share TP was raised from HKD150 to HKD172, while the A-share TP was lifted from RMB150 to RMB155. (ec/u)

Related NewsJPM: Profit-taking in China Pharma Sector Presents Good Entry Opportunity


This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.
Auto-translated by AI

AASTOCKS Financial News